Doctor profile · Federal record
Dr. PALLAVI RASTOGI, MD
Medical Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · PAOLI, PA
- NPI 1538125992
- Accepts Medicare
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
255 W LANCASTER AVE
PAOLI, PA 193011763
(484) 565-1600
fax (610) 647-2006
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- October 8, 2015
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Pennsylvania #MD425319
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538125992. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,770
Distinct HCPCS
10
Medicare allowed
$365,715
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 9,600 | 30 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 423 | 191 | $133 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 236 | 117 | $186 | |
96372 |
Injection of drug or substance under skin or into muscle | 137 | 44 | $15 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 94 | 68 | $51 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 83 | 79 | $134 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 62 | 46 | $81 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 37 | 37 | $223 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 28 | 27 | $178 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 22 | 18 | $123 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 828. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$897
Transactions
30
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 3 | $139.41 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $116.41 | |
| AstraZeneca Pharmaceuticals LP | 4 | $84.73 | |
| Celgene Corporation | 3 | $65.66 | |
| Merck Sharp & Dohme LLC | 2 | $55.74 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50.11 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46.67 | |
| SOBI, INC | 2 | $44.17 | |
| Tempus AI, Inc | 2 | $43.85 | |
| Eisai Inc. | 2 | $41.41 | |
| Alexion Pharmaceuticals, Inc. | 2 | $40.13 | |
| Novartis Pharmaceuticals Corporation | 2 | $38.68 | |
| Incyte Corporation | 1 | $29.79 | |
| Kite Pharma, Inc. | 1 | $26.87 | |
| Astellas Pharma US Inc | 1 | $21.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
730
Patients
195
Total drug cost
$1,455,931
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 180 | 46 | $4,086 |
| Ondansetron Hcl | Generic | 70 | 39 | $527 |
| Prochlorperazine Maleate | Generic | 63 | 38 | $656 |
| Letrozole | Generic | 60 | 19 | $1,943 |
| Eliquis (Apixaban) | Brand | 59 | 14 | $55,405 |
| Gabapentin | Generic | 55 | 14 | $316 |
| Xarelto (Rivaroxaban) | Brand | 41 | 11 | $45,113 |
| Tamoxifen Citrate | Generic | 38 | 14 | $1,116 |
| Ibrance (Palbociclib) | Brand | 28 | 0 | $423,417 |
| Imbruvica (Ibrutinib) | Brand | 27 | 0 | $560,372 |